Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators

Open source

DOI: 10.1056/nejmoa1009638
Published: 2011 Sep 8
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1009638,
  title = {Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.},
  author = {Patel MR and Mahaffey KW and Garg J and Pan G and Singer DE and Hacke W and Breithardt G and Halperin JL and Hankey GJ and Piccini JP and Becker RC and Nessel CC and Paolini JF and Berkowitz SD and Fox KA and Califf RM and ROCKET AF Investigators},
  year = {2011},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1009638},
  url = {https://doi.org/10.1056/nejmoa1009638}
}

RIS

TY  - JOUR
TI  - Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
AU  - Patel MR
AU  - Mahaffey KW
AU  - Garg J
AU  - Pan G
AU  - Singer DE
AU  - Hacke W
AU  - Breithardt G
AU  - Halperin JL
AU  - Hankey GJ
AU  - Piccini JP
AU  - Becker RC
AU  - Nessel CC
AU  - Paolini JF
AU  - Berkowitz SD
AU  - Fox KA
AU  - Califf RM
AU  - ROCKET AF Investigators
PY  - 2011
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1009638
UR  - https://doi.org/10.1056/nejmoa1009638
ER  -

APA

MR, P., KW, M., J, G., G, P., DE, S., W, H., G, B., JL, H., GJ, H., JP, P., RC, B., CC, N., JF, P., SD, B., KA, F., RM, C., & Investigators, R. A. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1009638

Source records

pubmed · retrieved 2026-09-25T13:13:40.578Z